×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Trident Lifeline Limited | NA | NA | NA | NA | 343.0 | 21.4 |
| Hemant Surgical Industries Lim | NA | NA | NA | NA | 340 | 42.5 |
| LYKA LABS LTD. | 298.43 | 8.14 | 291.76 | 0.22 | 339 | 45.1 |
Trident Lifeline Limited, with Security Code 543616, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Jun 2024 |
|---|---|---|---|---|---|---|
| Sales | 13.8 | 9.4 | 17.9 | 8.6 | 18.6 | 14.7 |
| Expenses | 11.5 | 7.4 | 13.9 | 6.9 | 14.6 | 10.7 |
| Operating Profit | 2.3 | 2.0 | 3.9 | 1.8 | 4.0 | 4.1 |
| OPM % | 16.8% | 21.03% | 21.99% | 20.41% | 21.29% | 27.67% |
| Other Income | 0.1 | 0.4 | 1.0 | 0.3 | 0.7 | 0.5 |
| Interest | 0.2 | 0.1 | 0.3 | 0.1 | 0.2 | 0.2 |
| Depreciation | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 0.3 |
| Profit before tax | 2.1 | 2.1 | 4.4 | 1.9 | 4.2 | 4.0 |
| Tax % | -5.7% | -4.8% | -9.9% | -24.6% | -25.4% | -25.1% |
| Net Profit | 2.0 | 2.0 | 4.0 | 1.4 | 3.1 | 3.0 |
| EPS in Rs | 2.8 | 1.77 | 3.49 | 1.22 | 2.7 | 2.62 |
| Metrics | Dec 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Sales | 9.4 | 8.6 | 13.2 |
| Expenses | 7.4 | 6.9 | 10.7 |
| Operating Profit | 2.0 | 1.8 | 2.5 |
| OPM % | 21.03% | 20.41% | 18.99% |
| Other Income | 0.4 | 0.3 | 1.2 |
| Interest | 0.1 | 0.1 | 0.5 |
| Depreciation | 0.1 | 0.1 | 0.5 |
| Profit before tax | 2.1 | 1.9 | 2.6 |
| Tax % | -4.8% | -24.6% | -38.7% |
| Net Profit | 2.0 | 1.4 | 1.6 |
| EPS in Rs | 1.77 | 1.22 | 1.39 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 69% |
| 3 Years: | 46% |
| TTM: | 52% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 78% |
| 3 Years: | 49% |
| TTM: | 86% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 58% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 59% |
| TTM: | 95% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 39% |
| TTM: | 77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 58% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|